Life Sciences organizations face a range of complex challenges including patent losses, merger and acquisition activity, and pressure to identify and accelerate time-to-market for new drugs. As Life Sciences companies navigate the turbulence of industry change, executives are looking for … Continue reading
Author information
The post Did You Move the ECM Needle Forward in 2015? appeared first on EMC Spark.